Indian pharmaceutical stocks took a hit as Trump’s threat of imposing tariffs on pharma imports spooked investors. Despite India’s strong presence in the US generics market, potential tariffs may increase costs for US consumers and create supply chain challenges.
High risk, high reward S Korea to debut AI-boom linked ETFs
South Korea is launching its first single-stock leveraged ETFs, linked to chipmakers Samsung Electronics and SK Hynix, aiming to double daily stock movements. These products